Your browser doesn't support javascript.
loading
Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis.
Maiseyeu, Andrei; Di, Lin; Ravodina, Anastasia; Barajas-Espinosa, Alma; Sakamoto, Atsushi; Chaplin, Alice; Zhong, Jixin; Gao, Huiyun; Mignery, Matthew; Narula, Navneet; Finn, Aloke V; Rajagopalan, Sanjay.
Afiliación
  • Maiseyeu A; Case Western Reserve University, Cleveland, OH.
  • Di L; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH.
  • Ravodina A; University of Maryland, Baltimore, MD.
  • Barajas-Espinosa A; Case Western Reserve University, Cleveland, OH.
  • Sakamoto A; Case Western Reserve University, Cleveland, OH.
  • Chaplin A; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH.
  • Zhong J; CVPath Institute, Inc., Gaithersburg, MD.
  • Gao H; Case Western Reserve University, Cleveland, OH.
  • Mignery M; Case Western Reserve University, Cleveland, OH.
  • Narula N; Case Western Reserve University, Cleveland, OH.
  • Finn AV; Case Western Reserve University, Cleveland, OH.
  • Rajagopalan S; NYU Langone Medical Center, New York, NY.
Theranostics ; 12(6): 2741-2757, 2022.
Article en En | MEDLINE | ID: mdl-35401813

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica / Receptor del Péptido 1 Similar al Glucagón Límite: Animals Idioma: En Revista: Theranostics Año: 2022 Tipo del documento: Article Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica / Receptor del Péptido 1 Similar al Glucagón Límite: Animals Idioma: En Revista: Theranostics Año: 2022 Tipo del documento: Article Pais de publicación: Australia